CTXR earnings: a positive outcome, +13.5%

On February 14, 2024, Citius Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +13.5% in the window around the event. It had already run -12.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.